End User and Primary Care Physicians’ Perspectives on Digital Innovations in Dementia Risk Detection: Focus on a Digital Sleep Biomarker
End users would find the DRI-SI acceptable as part of their clinical care, but primary care physicians require a more robust evidence base. Future research should explore the integration of the DRI-SI into clinical care/research pathways to enhance clinical acceptability. Five key recommendations have been made for further development of digital biomarkers for dementia risk populations.
Authors
- Marie Poole (ORCID: https://orcid.org/0000-0001-8379-7462)
- David Sharp (ORCID: https://orcid.org/0000-0002-1034-8567)
- Jonathan M. Schott (ORCID: https://orcid.org/0000-0003-2059-024X)
- Sophie Horrocks (ORCID: https://orcid.org/0000-0002-9139-2016)
- Matthew Harrison (ORCID: https://orcid.org/0000-0002-4905-5737)
- Louise Robinson (ORCID: https://orcid.org/0000-0003-0209-2503)
- Josh King‐Robson (ORCID: https://orcid.org/0000-0002-3662-9404)
- Ríona Mc Ardle (ORCID: https://orcid.org/0000-0001-7959-3563)
Institutions
- UK Dementia Research Institute (GB)
- NIHR Newcastle Biomedical Research Centre (GB)
- NIHR Queen Square Dementia Biomedical Research Unit (GB)
- University College London (GB)
- Imperial College London (GB)
- Newcastle University (GB)
Publication Details
- Journal
- JMIR Aging
- Published
- 2025-11-06
- DOI
- https://doi.org/10.2196/74307
- Primary Topic
- Sleep and related disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00